ATAI Life Sciences NV (ATAI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -45.521 | -195.6 | -63.84 | -42.352 | -13.432 |
Return on Equity (%) | -47.413 | -219.144 | -69.727 | -46.764 | -15.772 |
Return on Invested Capital (%) | -92.079 | -168.258 | -60.064 | -48.282 | -60.04 |
Operating Margin (%) | N/A | N/A | -670.401 | -58018.026 | -11665.605 |
Net Profit Margin (%) | N/A | N/A | -823.557 | -65401.288 | -12810.191 |
Book Value Per Share | 10.52 | 13.299 | 2.402 | 1.602 | 1.472 |
Earnings Per Share | -2.494 | -23.685 | -1.044 | -0.918 | -0.242 |
Cash Per Share | 5.303 | 13.561 | 2.255 | 1.149 | 0.271 |
Working Capital Per Share | 6.622 | 12.167 | 2.204 | 1.611 | 0.997 |
Operating Profit Per Share | N/A | N/A | 0.127 | 0.001 | 0.002 |
EBIT Per Share | -3.082 | -14.198 | -0.85 | -0.815 | -0.237 |
EBITDA Per Share | -3.082 | -14.198 | -0.85 | -0.815 | -0.237 |
Free Cash Flow Per Share | -2.491 | -23.676 | -1.043 | -0.914 | -0.241 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,67M | 7,17M | 160,68M | 165,94M | 166,03M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 165,94M | 165,94M | 166,01M | 165,94M | 166,03M | 166,03M | 167,77M | 167,82M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -87929.73 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -89554.054 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 206,4M |
Ratio cours/bénéfice | -5,21 |
Ratio prix/ventes | 657,89 |
Ratio prix/liquidités | 4,66 |
Ratio prix/valeur comptable | 0,86 |
Rendement de dividende | - |
Actions en circulation | 167,8M |
Volume moyen (1 semaine) | 1,35M |
Volume moyen (1 mois) | 1,18M |
Variation sur 52 semaines | -10,00% |
Plus haut sur 52 semaines | 2,85 |
Plus bas sur 52 semaines | 1,03 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales